Odyssey Therapeutics (NASDAQ:ODTX) Price Target Raised to $29.00

Дата публикации: 10-08-2026 05:36:48

Odyssey Therapeutics (NASDAQ:ODTX – Free Report) had its price target boosted by JPMorgan Chase & Co. from $26.00 to $29.00 in a research note released on Friday,Benzinga reports. JPMorgan Chase & Co. currently has an overweight rating on the stock. A number of other brokerages also recently commented on ODTX. Wedbush assumed coverage on shares […]

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	TG Therapeutics (NASDAQ:TGTX) Price Target Raised to $72.00	0	13.04	10-08-2026
2	Doximity (NYSE:DOCS) Price Target Raised to $31.00	0	12.67	10-08-2026
3	Royalty Pharma (NASDAQ:RPRX) Price Target Raised to $62.00	0	13.82	10-08-2026
4	Replimune Group (NASDAQ:REPL) Price Target Raised to $20.00	0	13.83	10-08-2026
5	Once Upon A Farm (NYSE:OFRM) Price Target Raised to $26.00	0	12.63	10-08-2026
6	Natera (NASDAQ:NTRA) Price Target Raised to $360.00	0	14.27	10-08-2026
7	Target (NYSE:TGT) Price Target Raised to $157.00	0	13.85	10-08-2026
8	Rhythm Pharmaceuticals (NASDAQ:RYTM) Price Target Raised to $146.00	0	14.22	10-08-2026
9	Sotera Health (NASDAQ:SHC) Price Target Raised to $18.00	0	12.25	10-08-2026

Классификация: Экономика. Схожих патентов: 0. Схожих новостей: 9. Тональность: 0. Информативность: 14.24. Источник: www.americanbankingnews.com.